Literature DB >> 12545707

[Pathophysiological alterations in cultured astrocytes exposed to hypoxia/reoxygenation].

H Xiong1, W L Liang, X R Wu.   

Abstract

While the research of hypoxic-ischemic injury to the central nervous system has been focused on neurons, astrocytes are also critically involved in and contribute to the hypoxic-ischemic process. The role these cells play appears to be more and more important. There are considerable progress in characterizing the pathophysiological alterations of these cells during hypoxic-ischemic brain damage.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 12545707

Source DB:  PubMed          Journal:  Sheng Li Ke Xue Jin Zhan        ISSN: 0559-7765


  9 in total

Review 1.  Blood-based diagnostics of traumatic brain injuries.

Authors:  Stefania Mondello; Uwe Muller; Andreas Jeromin; Jackson Streeter; Ronald L Hayes; Kevin K W Wang
Journal:  Expert Rev Mol Diagn       Date:  2011-01       Impact factor: 5.225

2.  Ubiquitin C-terminal hydrolase is a novel biomarker in humans for severe traumatic brain injury.

Authors:  Linda Papa; Linnet Akinyi; Ming Cheng Liu; Jose A Pineda; Joseph J Tepas; Monika W Oli; Wenrong Zheng; Gillian Robinson; Steven A Robicsek; Andrea Gabrielli; Shelley C Heaton; H Julia Hannay; Jason A Demery; Gretchen M Brophy; Joe Layon; Claudia S Robertson; Ronald L Hayes; Kevin K W Wang
Journal:  Crit Care Med       Date:  2010-01       Impact factor: 7.598

Review 3.  Systematic review of clinical studies examining biomarkers of brain injury in athletes after sports-related concussion.

Authors:  Linda Papa; Michelle M Ramia; Damyan Edwards; Brian D Johnson; Semyon M Slobounov
Journal:  J Neurotrauma       Date:  2015-01-23       Impact factor: 5.269

4.  GFAP out-performs S100β in detecting traumatic intracranial lesions on computed tomography in trauma patients with mild traumatic brain injury and those with extracranial lesions.

Authors:  Linda Papa; Salvatore Silvestri; Gretchen M Brophy; Philip Giordano; Jay L Falk; Carolina F Braga; Ciara N Tan; Neema J Ameli; Jason A Demery; Neha K Dixit; Matthew E Mendes; Ronald L Hayes; Kevin K W Wang; Claudia S Robertson
Journal:  J Neurotrauma       Date:  2014-09-12       Impact factor: 5.269

5.  αII-spectrin breakdown products (SBDPs): diagnosis and outcome in severe traumatic brain injury patients.

Authors:  Stefania Mondello; Steven A Robicsek; Andrea Gabrielli; Gretchen M Brophy; Linda Papa; Joseph Tepas; Claudia Robertson; Andras Buki; Dancia Scharf; Mo Jixiang; Linnet Akinyi; Uwe Muller; Kevin K W Wang; Ronald L Hayes
Journal:  J Neurotrauma       Date:  2010-07       Impact factor: 5.269

6.  Current Trends in Biomarkers for Traumatic Brain Injury.

Authors:  Tejas Mehta; Muniba Fayyaz; Gema E Giler; Harleen Kaur; Sudhanshu P Raikwar; Duraisamy Kempuraj; Govindhasamy Pushpavathi Selvakumar; Mohammad Ejaz Ahmed; Ramasamy Thangavel; Smita Zaheer; Shankar Iyer; Raghav Govindarajan; Asgar Zaheer
Journal:  Open Access J Neurol Neurosurg       Date:  2020-01-08

7.  Biomarkers improve clinical outcome predictors of mortality following non-penetrating severe traumatic brain injury.

Authors:  Linda Papa; Claudia S Robertson; Kevin K W Wang; Gretchen M Brophy; H Julia Hannay; Shelley Heaton; Ilona Schmalfuss; Andrea Gabrielli; Ronald L Hayes; Steven A Robicsek
Journal:  Neurocrit Care       Date:  2015-02       Impact factor: 3.210

8.  S100 Calcium-Binding Protein B and Glial Fibrillary Acidic Protein in Patients with Mild Traumatic Brain Injury.

Authors:  Ali Meshkini; Amir Ghorbani Haghjo; Zahra Hasanpour Segherlou; Masoud Nouri-Vaskeh
Journal:  Bull Emerg Trauma       Date:  2021-10

Review 9.  Review of the potential use of blood neuro-biomarkers in the diagnosis of mild traumatic brain injury.

Authors:  Alastair Jones; Paul Jarvis
Journal:  Clin Exp Emerg Med       Date:  2017-09-30
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.